跳至主要内容
临床试验/NCT06883045
NCT06883045招募中不适用

A Novel mHealth Intervention to Improve Outcomes of Children With Medical Complexity

University of Utah2 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2026年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
360
试验地点
2
主要终点
ED/hospital admissions

研究概览

简要总结

Children with medical complexity (CMC) are the most vulnerable of children with chronic diseases, who have complex, multisystem chronic diseases affecting ≥3 organ systems, severe functional limitations and technology dependencies. CMC have high health care needs, and account for 40% of hospitalized children and 35% of all pediatric health care costs. Due to high medical fragility, CMC have frequent acute deteriorations superimposed on their chronic conditions, leading to recurrent emergency department (ED)/hospital admissions and affecting quality of life (QOL). To reduce ED/hospital admissions for CMC, remote monitoring is suggested, with use of mHealth apps to regularly assess their health status remotely and identify early signs of acute deterioration, allowing for early interventions to prevent ED/hospital admissions. Yet no app to support remote monitoring of CMC exists. Variable, multisystem conditions among CMC make it difficult to develop an app. Also, many CMC are at high-risk for health care inequities, with minorities having higher unmet needs, but the impacts of health care inequities and social determinants of health (SDOH) on ED/hospital admissions in CMC are rarely studied. Fortunately, ED/hospital admissions for CMC are often preceded by a limited set of shared (crosscutting) acute symptoms. These crosscutting symptoms rarely occur suddenly. Studies suggest that they usually start as subtle signs, often unnoticed by parents until they escalate to prompt an ED/hospital visit. Thus, crosscutting symptoms offer an opportunity for a novel and practical approach for developing a remote monitoring app for CMC, despite their multiple, variable underlying conditions. In a focus group, parents identified the crosscutting symptoms that most often preceded their children's hospital admissions, and conveyed their needs, preferences and key functionalities that led to MyChildCMC, the first app designed to monitor and identify early signs of crosscutting symptoms in CMC. In a pilot trial of 50 subjects, we confirmed feasibility of MyChildCMC use by parents, ability to detect early signs 2-14 days prior to ED/hospital admissions, and use leading significantly to fewer hospital days than controls. The current study will assess the efficacy and sustainability of MyChildCMC in a fully-powered 6-month, 2-arm (MyChildCMC vs usual care) trial of CMC (age 1-18 years) and their parents. Parents assigned to MyChildCMC will use the app daily for 6 months, both arms will receive financial incentive for participation, then we will stop the incentive and follow subjects for 6 more months to assess sustainability at 12 months. We will also assess if MyChildCMC use will help reduce or eliminate inequities in ED/hospital admissions. Specific Aims are: 1) Determine MyChildCMC's efficacy on 1.a. Child (ED/hospital use, hospital days and QOL) and 1.b. Parent (satisfaction, self-efficacy and stress) outcomes; 2) Compare ED/hospital use among racial/ethnic and SDOH subgroups to assess potential effect of MyChildCMC on inequities.

详细描述

Children with medical complexity (CMC) have complex, multisystem chronic diseases, neurological impairments with marked intellectual/physical disabilities, functional limitations, technology dependencies, high medical fragility, and account for 35% of all pediatric US health care costs. Compared to typically developing children, CMC have frequent acute health deteriorations, leading to recurrent emergency department (ED)/hospital visits.

CMC have significant daily care needs, requiring continuous care at home and substantial care coordination. Care coordination programs exist to support CMC's daily care needs, including medical homes, home health care, hospital-to-home transition, and complex care services. Observational studies of these programs report some reductions in admissions, length of stay and costs. Despite these care coordination programs, CMC continue to have frequent acute deteriorations of their health that affect their quality of life (QOL) and lead to recurrent ED/hospital admissions, many of which are avoidable with early detection and intervention.

Remote monitoring with support of mHealth apps has been suggested to improve CMC care, QOL, and help reduce their ED/hospital admissions. This can be done via regular assessment of CMC's health status and detection of early signs of deteriorations to prompt early interventions. Unfortunately, no remote monitoring app for CMC exists. Available remote monitoring apps target primarily non-complex single chronic conditions (e.g. asthma, diabetes). Variable, multisystem conditions make it difficult to develop a remote monitoring app for CMC.

ED/hospital admissions for CMC are often preceded by a limited set of shared (crosscutting) acute symptoms: fever, respiratory distress with decreased oxygenation, feeding/fluid intolerance, altered mental status (sometimes seizures), and pain. These symptoms rarely occur suddenly. Studies suggest that they usually start as subtle signs (e.g. change in vital signs), often unnoticed by parents until they escalate to prompt an ED/ hospital visit. Thus, crosscutting symptoms provide an opportunity for a novel and practical approach for remote monitoring. In a focus group we conducted, CMC parents identified these crosscutting symptoms preceding most of their CMC's admissions. They also conveyed their needs, preferences and key functionalities that led to MyChildCMC, the first app for CMC remote monitoring, which has: 1) automated daily reminders, 2) crosscutting symptom monitoring, 3) automated feedback, 4) automated reporting with graphs, and 5) automated alerts.

In a 3-month pilot trial of 50 CMC randomized to MyChildCMC (n=24) or usual care (n=26) our team conducted, MyChildCMC use by parents showed high feasibility (high participation, adherence and retention), ability to detect early signs of crosscutting symptoms 2-14 days prior to most ED/hospital admissions, fewer hospital days, and higher parent satisfaction than controls. But, MyChildCMC's efficacy for ED/hospital admissions has yet to be demonstrated in a fully powered study (pilot was not powered for number of ED/hospital admissions).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •CMC, ages 1-18 years and their parents (or primary caregivers)
  • •CMC (inpatients or outpatients) who receive care at participating sites (comprehensive care clinics for CMC)
  • •Own (or provided) a smartphone or tablet with internet access
  • •Speak English or Spanish.
  • •CMCs are identified using an operational definition, as having: 1) multisystem chronic diseases involving ≥3 organ systems, 2) ≥3 HCPs involved in their care, 3) high fragility or frequent (≥2) or 1 prolonged (>10 days) hospitalization in the prior year, and/or 4) medical technology dependence.

排除标准

  • •Critically ill CMC and infants.
  • •CMC exhibit similar developmental and functional abilities and typically function below expected for a 7-year-old child, allowing inclusion of a wide age range in studies.
  • •Infants were excluded as many CMC <1 year have prematurity-related conditions that may resolve by age
  • •CMC >18 years of age were not included as some may transition to adult health care.
  • •Note: No one will be excluded due to lack of smartphone/internet access. We estimated <10% of families may not have a smartphone/internet, and will provide them low-cost tablets and cellular internet access.

研究组 & 干预措施

MyChildCMC group

Experimental

MyChildCMC is an app designed to support remote monitoring of CMC crosscutting symptoms to identify signs of CMC's health deterioration early to change their care early to avoid progression and prevent ED/hospital admissions. The app includes the following features: 1) automated reminders, 2) vital sign/symptom monitoring, 3) real-time feedback system, 4) automated and real-time summary reports with longitudinal graphs, 5) automated alerts to a care coordinator, and 6) clinic dashboard connecting patients to clinics and allowing access to patient data to support care coordination. Those randomized to MyChildCMC will use the app daily for 6 months to monitor vital signs/symptoms. They will also receive a sensor (Masimo Mighty Sat) to facilitate collection of Oxygen saturation, heart rate and respiratory rate, as well as financial incentive for daily monitoring (monitoring incentive) for 6-months and for responding to surveys.

干预措施: MyChildCMC app (an app designed to facilitate home monitoring of CMC's health status) (Other)

Usual care group

Active Comparator

Those assigned to usual care will use a paper diary to monitor their vital signs and symptoms daily for 6 months. They will also receive a sensor (Masimo Mighty Sat) to facilitate collection of Oxygen saturation, heart rate and respiratory rate, as well as financial incentive for daily monitoring (monitoring incentive) for 6-months and for responding to surveys.

干预措施: MyChildCMC app (an app designed to facilitate home monitoring of CMC's health status) (Other)

结局指标

主要结局

ED/hospital admissions

时间窗: 6-month pre and 6-month post enrollment

Numbers of ED and hospital admissions will be assessed pre-post enrollment.

次要结局

  • Child's quality of life (QOL)(Baseline, 1 month, 3 months and 6 months post-enrollment)
  • Self-efficacy scale(Baseline, 1 month, 3 months and 6 months post-enrollment)
  • Caregiver stress(Baseline, 1 month, 3 months and 6 months post-enrollment)
  • Parent satisfaction(Baseline and 6 months post-enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Flory Nkoy

Professor

University of Utah

研究点 (2)

Loading locations...

相似试验